ProfileGDS4718 / 1570650_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 17% 28% 18% 27% 18% 13% 18% 26% 12% 27% 23% 21% 16% 14% 16% 23% 24% 19% 18% 19% 25% 20% 18% 25% 16% 19% 26% 14% 12% 18% 19% 16% 24% 24% 12% 9% 19% 24% 23% 21% 20% 17% 17% 17% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0317
GSM549102patient 115, normal, homogenized [OPG study]4.4810928
GSM549104patient 119, normal, homogenized [OPG study]4.0583618
GSM549108patient 138, normal, homogenized [OPG study]4.4565927
GSM549119patient 077, normal, homogenized [OPG study]4.0718118
GSM549133patient 032, cancer, homogenized [OPG study]3.8500313
GSM549139patient 042, cancer, homogenized [OPG study]4.0412218
GSM549099patient 107, normal, homogenized [OPG study]4.3997926
GSM549109patient 139, normal, homogenized [OPG study]3.8916812
GSM549110patient 046, normal, homogenized [OPG study]4.4084827
GSM549114patient 063, normal, homogenized [OPG study]4.2247723
GSM549122patient 082, normal, homogenized [OPG study]4.1906921
GSM549134patient 033, cancer, homogenized [OPG study]3.9856516
GSM549136patient 036, cancer, homogenized [OPG study]3.881714
GSM549140patient 044, cancer, homogenized [OPG study]3.9575416
GSM549111patient 047, normal, homogenized [OPG study]4.2400623
GSM549113patient 057, normal, homogenized [OPG study]4.2350224
GSM549132patient 031, cancer, homogenized [OPG study]4.1119
GSM549137patient 038, cancer, homogenized [OPG study]4.0443418
GSM549142patient 047, cancer, homogenized [OPG study]4.2003219
GSM549100patient 110, normal, homogenized [OPG study]4.3543625
GSM549107patient 135, normal, homogenized [OPG study]4.1293220
GSM549115patient 068, normal, homogenized [OPG study]4.0371318
GSM549116patient 072, normal, homogenized [OPG study]4.3234625
GSM549120patient 078, normal, homogenized [OPG study]4.005716
GSM549131patient 030, cancer, homogenized [OPG study]4.0541619
GSM549118patient 074, normal, homogenized [OPG study]4.3693726
GSM549129patient 027, cancer, homogenized [OPG study]3.9290714
GSM549123patient 088, normal, homogenized [OPG study]3.8444112
GSM549124patient 006, cancer, homogenized [OPG study]4.1156218
GSM549126patient 015, cancer, homogenized [OPG study]4.0919619
GSM549128patient 025, cancer, homogenized [OPG study]3.9561516
GSM549103patient 117, normal, homogenized [OPG study]4.3654324
GSM549117patient 073, normal, homogenized [OPG study]4.2771624
GSM549138patient 041, cancer, homogenized [OPG study]3.8211712
GSM549141patient 045, cancer, homogenized [OPG study]3.712269
GSM549130patient 028, cancer, homogenized [OPG study]4.1233219
GSM549101patient 111, normal, homogenized [OPG study]4.329724
GSM549105patient 128, normal, homogenized [OPG study]4.2606823
GSM549106patient 134, normal, homogenized [OPG study]4.1200321
GSM549112patient 048, normal, homogenized [OPG study]4.1216720
GSM549125patient 011, cancer, homogenized [OPG study]4.0594417
GSM549127patient 024, cancer, homogenized [OPG study]4.024117
GSM549135patient 035, cancer, homogenized [OPG study]3.9698917